TRIO Pharmaceuticals
CA - San CarlosPharmaceutical
Focus: TRIO Pharmaceuticals is a publicly traded company focused on cancer immunotherapeutics based in San Carlos, CA, with early-stage pipeline programs in oncology and neurology.
Profile data last refreshed 5h ago · AI intelligence enriched 4d ago
Funding Stage
PUBLIC
Total Funding
$300M
Open Jobs
1
Should You Work at TRIO Pharmaceuticals?
AI assessmentTRIO presents high scientific upside in immunotherapy but carries significant execution risk due to early-stage pipeline, minimal hiring, and opaque financials—suitable only for risk-tolerant early-stage specialists.
Why Work Here
- Public company status provides equity upside potential and established governance structures absent in early-stage biotech.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
YF476
Reflux OesophagitisClinical Trials (1)
NCT01538784Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men
Phase 1Help build intelligence for TRIO Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.